Showing 15,861 - 15,880 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly ((linear decrease) OR (a decrease)) ))', query time: 0.67s Refine Results
  1. 15861

    Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles by Alejandra Verhassel (19823895)

    Published 2024
    “…<p><b>Aim:</b> Fluorescence detection of breast and prostate cancer cells expressing Tn-antigen, a tumor marker, with <i>Vicia villosa</i> lectin (VVL)-labeled nanoparticles.…”
  2. 15862

    Image 1_Global, regional and national burdens of otitis media in children and adolescents from 1990 to 2021 and its predictions to 2040.tiff by Ru Chen (186859)

    Published 2025
    “…Regionally, both mortality rates and DALYs significantly decrease with increasing SDI. Sub-Saharan Africa and South Asia have high levels of incidence and prevalence. …”
  3. 15863

    Table 2_Global, regional and national burdens of otitis media in children and adolescents from 1990 to 2021 and its predictions to 2040.docx by Ru Chen (186859)

    Published 2025
    “…Regionally, both mortality rates and DALYs significantly decrease with increasing SDI. Sub-Saharan Africa and South Asia have high levels of incidence and prevalence. …”
  4. 15864

    Image 4_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  5. 15865

    Image 2_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  6. 15866

    Image 1_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  7. 15867

    Image 5_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  8. 15868

    Table 1_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.docx by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  9. 15869

    Image 3_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

    Published 2025
    “…In parallel, spectral imaging further revealed post-treatment shifts in macrophage populations, with a significant decrease in inflammatory subsets (CD14+, CD14+/Mac387+, p<0.05) and an increase in anti-inflammatory subsets (CD16+, CD16+/CD163+, CD16+/CD68+, p<0.05). …”
  10. 15870

    Data Sheet 1_Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis.docx by Rita Spathis (187690)

    Published 2025
    “…</p>Results<p>Viral load was significantly increased by 77-fold in white blood cells after two rAAV9-microdystrophin doses compared to mice receiving a single dose. …”
  11. 15871

    Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis by Fateen Ata (12217764)

    Published 2024
    “…<p>The increasing prevalence of diabetic ketoacidosis (DKA) related admissions poses a significant burden on the healthcare systems globally. …”
  12. 15872

    Ydj1 acetylation alters interactions with client proteins. by Siddhi Omkar (12413434)

    Published 2024
    “…Interactors are colored according to change in interaction as follows: green (significant increase), red (significant decrease), or purple (no significant change) 6KQ/6KR. …”
  13. 15873

    Figure 1 from Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma by Edgar Gonzalez-Kozlova (18366814)

    Published 2025
    “…<b>C,</b> Summary heatmap showing the log<sub>2</sub>-fold change (log<sub>2</sub>FC) between time points and treatments. The changes with a positive log<sub>2</sub>FC over time in color blue are associated with a decrease over time and red with an increase over time. …”
  14. 15874

    Live/Dead cells 4 days incubation. by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  15. 15875

    CPSF6-NLS chimeras confer virus-specific infectivity defects. by Nicholas Rohlfes (20577485)

    Published 2025
    “…Relative infectivity in CsA-treated growth arrested cells to untreated WT HIV-1-infected (C) and P90A infected (D) growth arrested cells displays a decrease to no change in infectivity for all CPSF6-NLS cell lines except for CPSF6-NP NLS cells during WT HIV-1 infection, which display an almost twofold increased infection. …”
  16. 15876

    ESR Fig 4, Table 1 data. by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  17. 15877

    Table 2_Wip1 inhibitor CCT007093 alleviates immune exhaustion of lymphocytes via p65 NF-κB and YY1 in chronic hepatitis B virus infection in mice.xlsx by Yu-Syuan You (21288113)

    Published 2025
    “…</p>Methods<p>We focused on CCT007093, a Wip1 inhibitor, screened for its distinctive capacity to simultaneously decrease PD-1 and FcγRIIB expression in B cells.…”
  18. 15878

    Image 2_Wip1 inhibitor CCT007093 alleviates immune exhaustion of lymphocytes via p65 NF-κB and YY1 in chronic hepatitis B virus infection in mice.tif by Yu-Syuan You (21288113)

    Published 2025
    “…</p>Methods<p>We focused on CCT007093, a Wip1 inhibitor, screened for its distinctive capacity to simultaneously decrease PD-1 and FcγRIIB expression in B cells.…”
  19. 15879

    Image 7_Wip1 inhibitor CCT007093 alleviates immune exhaustion of lymphocytes via p65 NF-κB and YY1 in chronic hepatitis B virus infection in mice.tif by Yu-Syuan You (21288113)

    Published 2025
    “…</p>Methods<p>We focused on CCT007093, a Wip1 inhibitor, screened for its distinctive capacity to simultaneously decrease PD-1 and FcγRIIB expression in B cells.…”
  20. 15880

    Image 6_Wip1 inhibitor CCT007093 alleviates immune exhaustion of lymphocytes via p65 NF-κB and YY1 in chronic hepatitis B virus infection in mice.tif by Yu-Syuan You (21288113)

    Published 2025
    “…</p>Methods<p>We focused on CCT007093, a Wip1 inhibitor, screened for its distinctive capacity to simultaneously decrease PD-1 and FcγRIIB expression in B cells.…”